- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00866814
Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch
October 10, 2012 updated by: C. R. Bard
A Prospective, Single Arm, Multi-Center Study Of Open Ventral Hernia Repair Utilizing The Bard Ventrio Hernia Patch
This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch.
The study will evaluate hernia recurrence rates, operating time, quality of life and complications associated with the device and surgical procedure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
119
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States
- Sutter Medical Group GNS
-
-
Florida
-
Pensacola, Florida, United States, 32504
- Sacred Heart Health System, Inc.
-
-
Illinois
-
Chicago, Illinois, United States
- Rush Univeristy Medical Center
-
Peoria, Illinois, United States
- Associated Surgical Group
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Carolinas Medical Center
-
Gastonia, North Carolina, United States, 28054
- Gaston Memorial Hospital
-
Winston-Salem, North Carolina, United States, 27103
- Novant Clinical Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects with a diagnosis of ventral hernia will be screened for eligibility against the study protocol inclusion and exclusion criteria utilizing standard preoperative criteria (e.g.
physical examination, blood work, medical evaluation, etc) which occurred within 30 days of the date of consent.
Description
Inclusion Criteria:
- Male or female, age ≥ 18
- Be able to undergo study procedures
- Have signed an Informed Consent form (ICF)
- Be diagnosed with a ventral hernia requiring an open surgery for repair.
Exclusion Criteria:
- Patient is participating in another device or drug study.
- Patient exhibits clinical symptoms indicating infected hernia site.
- Patient currently has a clean contaminated or contaminated site.
- Patient has a life expectancy less than 2 years at the time of enrollment.
- Anything in the opinion of the Investigator that would preclude the use of the Ventrio Hernia Patch, or preclude the subject from completing the follow-up requirements.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Ventrio Group
Patients diagnosed with a ventral hernia requiring an open surgery for repair.
|
The Ventrio Hernia Patch is a self-expanding, non-absorbable, sterile prosthesis for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Primary Endpoint is the Rate of Hernia Recurrence in Study Patients.
Time Frame: 1 year post surgery
|
A recurrent hernia is a hernia, confirmed by the investigator at any point within the first year after surgery, in the same location as the hernia repaired in the index procedure.
|
1 year post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perioperative Complications Will be Assessed by Evaluation of the Procedural and Device Related Adverse Events (AEs) Collected From the Time Surgery is Initiated Until the Day the Patient is Discharged From the Hospital.
Time Frame: From the time of surgery to hospital discharge, an average of 1-2 days
|
In this study, a complication was defined as any adverse event that was assessed by the Investigator as either possibly or definitely related to the study procedure or the study device.
|
From the time of surgery to hospital discharge, an average of 1-2 days
|
Short-term Complications Will be Assessed by Evaluation of the Procedural and Device Related AEs Collected From the Day After the Patient is Discharged From the Hospital Until 21 Days Post Procedure.
Time Frame: Hospital discharge through 21 days post surgery
|
In this study, a complication was defined as any adverse event that was assessed by the Investigator as either possibly or definitely related to the study procedure or the study device.
|
Hospital discharge through 21 days post surgery
|
Long-term Complications Will be Assessed by Evaluation of the Procedural and Device Related AEs Collected After 21 Days up to 1 Year.
Time Frame: 22 days post surgery through 1 year post surgery
|
In this study, a complication was defined as any adverse event that was assessed by the Investigator as either possibly or definitely related to the study procedure or the study device.
|
22 days post surgery through 1 year post surgery
|
Quality of Life Will be Assessed at Baseline Through 1 Year Utilizing the Carolinas Comfort Scale Survey
Time Frame: Baseline and post-surgery at week 2, month 6 and month 12
|
Mean Quality of Life scores at each study visit for the "sensation of mesh," "pain," and "movement limitation" components of the Carolinas Comfort Scale are reported.
Patient responses are provided on a ordinal scale from 0-5 indicating increasing severity of symptoms with 0 representing no symptoms and 5 representing disabling symptoms.
Sensation of mesh was not evaluable at baseline and therefore, scores are reported starting at 2 weeks post study procedure.
|
Baseline and post-surgery at week 2, month 6 and month 12
|
Procedure Time
Time Frame: Day of surgery
|
Procedure time will be defined as beginning when the investigator makes the initial incision and ending when the skin closure is completed.
|
Day of surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Iannitti, MD, FACS, Carolinas Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
May 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
March 20, 2009
First Submitted That Met QC Criteria
March 20, 2009
First Posted (Estimate)
March 23, 2009
Study Record Updates
Last Update Posted (Estimate)
October 12, 2012
Last Update Submitted That Met QC Criteria
October 10, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DVL-HE004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Universitaire Ziekenhuizen KU LeuvenBelgian Section for Abdominal Wall Surgery, section of the Royal Belgian...Not yet recruitingVentral Incisional Hernia
-
University of PennsylvaniaCompleted
Clinical Trials on Bard Ventrio Hernia Patch
-
San Bonifacio HospitalCompletedIndirect Inguinal Hernia | Direct Inguinal HerniaItaly
-
Skane University HospitalRegion SkaneCompletedChronic Pain | Sexual DysfunctionSweden
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Atrium...CompletedVentral Hernia | AdhesionsUnited States